Apple iPhones get bigger and pricier, Watch turns to
health
Send a link to a friend
[September 13, 2018]
By Stephen Nellis and Noel Randewich
CUPERTINO, Calif. (Reuters) - Apple Inc
introduced its largest-ever iPhone and a watch that detects heart
problems on Wednesday in an attempt to get customers to upgrade to more
expensive devices in the face of stagnant global demand for smartphones.
The relatively small changes to its lineup, following last year's
overhauled iPhone X, were widely expected by investors and the company's
shares ended down 1.2 percent at $221.07.
The strategy has been successful, helping Apple's stock to rise more
than 30 percent this year and making it the first publicly traded U.S.
company to hit a market value of more than $1 trillion.
Apple's new iPhone XS, pronounced "ten S," has a 5.8-inch (14.7-cm)
screen, and will be sold at a starting price of $999. The XS Max, the
largest iPhone to date and one of the biggest on the market, has a
6.5-inch (16.5-cm) screen, and will start selling at $1,099.
"They have finally added a larger-screen phone so that they can directly
compete with the Galaxy Note 9 products," Gartner analyst Annette
Zimmermann said at the event at Apple's Silicon Valley headquarters,
referring to rival Samsung Electronics which has led the trend toward
big-screen phones.
"The larger screen will be very important in China to turn around the
trend there, because they have lost some share in the last few years,
partly because of screen size," she added.
In China, the launch was the top trending topic on social media, with
one conversation about it being read more than 890 million times on
popular microblogging website Sina Weibo.
While online sentiment was mixed, an obvious key focus was the high
price tag - also a target of criticism around the launch of the iPhone X
last year.
"Before the launch I was thinking which kidney I should sell off, the
left or the right. Now the decision is made up. I'll have to sell off
both," joked one user on the platform.
Apple also introduced a lower-cost 6.1-inch (15.5 cm) iPhone XR made of
aluminum, at a starting price at $749.
The iPhone XS Max's display size is 26 percent larger than the previous
largest iPhone display, marking it the largest increase in screen size
since 2014, wrote analyst Gene Munster of Loup Ventures in a note.
This year's three top phones are all more expensive than last year's
models.
With two of them starting at $999 or higher in the United States, Apple
appears to be taking advantage of a strong U.S. economy, low
unemployment, and rising household wealth.
The median U.S. household income rose for a third straight year in 2017
to the highest on record since 1967 by one measure, government data
showed on Wednesday.
Graphic: Apple stock performance six months ahead of each iPhone launch
- https://reut.rs/2CJ8fgI
MEDICAL DEVICE MARKET
Looking for ways to lessen reliance on phones, which represent more than
60 percent its revenue, Apple opened its event by announcing the new
Apple Watch Series 4 with edge-to-edge displays, like its latest phones,
and they are more than 30 percent bigger than displays on current
models.
[to top of second column] |
Philip W. Schiller, Senior Vice President, Worldwide Marketing of
Apple, speaks about the the new Apple iPhone XR at an Apple Inc
product launch event at the Steve Jobs Theater in Cupertino,
California, U.S., September 12, 2018. REUTERS/Stephen Lam
It is positioning the new watch as a more comprehensive health device, able to
take an electrocardiogram to detect an irregular heartbeat and start an
emergency call automatically if it detects a user falling down, potentially
appealing to older customers.
The U.S. Food and Drug Administration said it worked with Apple to develop apps
for the Apple Watch and has been taking steps to ease the regulatory pathway for
companies seeking to create digital healthcare products.
As many as 6.1 million Americans have atrial fibrillation, a heart disease
involving irregular heart rhythm for which the Watch could offer an early
warning. That number is expected to double by 2050 as the population gets older,
according to the American Heart Association.
"This does have a lot of potential for patients," said Dr. Michael Valentine,
president of the American College of Cardiology and a cardiologist at Central
Health in Lynchburg, Virginia. "Clinicians face patients every day with
palpitations, rapid heart rates, and other symptoms," and the doctors want a
more portable monitoring and recording system.
BMO Capital Markets analyst Joanne Wuensch added that physicians would be
unlikely to make medical treatment based on data from the watch, though it could
encourage patients to see cardiologists.
Healthcare technology analyst Ross Muken at Evercore said many companies were
developing monitoring devices. "This update really establishes the company's
increasing efforts to push the watch as a serious medical device," he said of
Apple.
Shares of fitness device rival Fitbit Inc fell 6.9 percent after the Series 4
announcement on Wednesday.
Apple's event was held at the Steve Jobs Theater in its new circular
headquarters in Cupertino, California, named after the company's co-founder who
wowed the world with the first iPhone in 2007.
Executives made no mention of a wireless charging mat, or content deals for
Apple TV, as some industry analysts had expected.
"We all knew this was going to be a transitional but not transformational phone
update," said Trip Miller, managing partner at hedge fund Gullane Capital, which
owns Apple shares.
Graphic: Apple's Growth Seen Slowing - https://reut.rs/2CS6xt8
(Reporting by Sonam Rai in Bengaluru and Stephen Nellis in Cupertino,
California; Additional reporting by Deena Beasley in Los Angeles, Supantha
Mukherjee in Bengaluru, Nadine Schimroszik in Berlin and Yasmeen Abutaleb in
Washington, Adam Jourdan in Shanghai and Beijing newsroom; Writing by Bill
Rigby; Editing by Peter Henderson, Nick Zieminski and Himani Sarkar)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |